Delta-Fly Pharma, Inc. 4598.T Stock
Delta-Fly Pharma, Inc. Price Chart
Delta-Fly Pharma, Inc. 4598.T Financial and Trading Overview
| Delta-Fly Pharma, Inc. stock price | 816 JPY |
| Previous Close | 921 JPY |
| Open | 940 JPY |
| Bid | 916 JPY x 0 |
| Ask | 919 JPY x 0 |
| Day's Range | 915 - 951 JPY |
| 52 Week Range | 791 - 1560 JPY |
| Volume | 324.3K JPY |
| Avg. Volume | 714.61K JPY |
| Market Cap | 4.98B JPY |
| Beta (5Y Monthly) | 0.56375 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -186.45 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4598.T Valuation Measures
| Enterprise Value | 4.95B JPY |
| Trailing P/E | N/A |
| Forward P/E | -49.62162 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 7.304439 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.764 |
Trading Information
Delta-Fly Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 0.56375 |
| 52-Week Change | -0.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1560 JPY |
| 52 Week Low | 791 JPY |
| 50-Day Moving Average | 1130.18 JPY |
| 200-Day Moving Average | 1085.05 JPY |
4598.T Share Statistics
| Avg. Volume (3 month) | 714.61K JPY |
| Avg. Daily Volume (10-Days) | 470.98K JPY |
| Shares Outstanding | 5.42M |
| Float | 4.89M |
| Short Ratio | N/A |
| % Held by Insiders | 26.30% |
| % Held by Institutions | 13.23% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.71% |
| Return on Equity (ttm) | -131.35% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -1314000000 JPY |
| Net Income Avi to Common (ttm) | -1328000000 JPY |
| Diluted EPS (ttm) | -209.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 844M JPY |
| Total Cash Per Share (mrq) | 134.27 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 7.53 |
| Book Value Per Share (mrq) | 125.677 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1303000064 JPY |
| Levered Free Cash Flow (ttm) | -806875008 JPY |
Profile of Delta-Fly Pharma, Inc.
| Country | Japan |
| State | N/A |
| City | Tokushima |
| Address | 37-5 Nishikino |
| ZIP | 771-0116 |
| Phone | N/A |
| Website | https://www.delta-flypharma.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Delta-Fly Pharma, Inc. develops anticancer drugs. It develops DFP-10917 that is in phase III clinical trial in the United States and phase I trial in Japan for the treatment of relapsed/refractory acute myeloid leukemia; DFP-14323, which is in phase II clinical trial to treat lung cancer; DFP-17729 that is in phase I/II clinical trials for the treatment of solid cancer; DFP-11207, which has completed phase I clinical trial to treat pancreatic cancer; DFP-14927 that is in phase I for the treatment of hematologic cancer; and DFP-10825, which is in preclinical trial to treat gastric/ovarian cancer. The company was incorporated in 2010 and is headquartered in Tokushima, Japan.
Q&A For Delta-Fly Pharma, Inc. Stock
What is a current 4598.T stock price?
Delta-Fly Pharma, Inc. 4598.T stock price today per share is 816 JPY.
How to purchase Delta-Fly Pharma, Inc. stock?
You can buy 4598.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Delta-Fly Pharma, Inc.?
The stock symbol or ticker of Delta-Fly Pharma, Inc. is 4598.T.
Which industry does the Delta-Fly Pharma, Inc. company belong to?
The Delta-Fly Pharma, Inc. industry is Biotechnology.
How many shares does Delta-Fly Pharma, Inc. have in circulation?
The max supply of Delta-Fly Pharma, Inc. shares is 8.23M.
What is Delta-Fly Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
Delta-Fly Pharma, Inc. PE Ratio is now.
What was Delta-Fly Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
Delta-Fly Pharma, Inc. EPS is -186.45 JPY over the trailing 12 months.
Which sector does the Delta-Fly Pharma, Inc. company belong to?
The Delta-Fly Pharma, Inc. sector is Healthcare.